- ►oxfordjournals.org G Schernthaner - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Diabetic nephropathy (DNP) is a devasting disorder and is now worldwide the
leading cause of end-stage renal failure. This diabetic complication is a
complex disease, whereby various genetic and environmental factors ... Cited by 4 - Related articles - BL Direct - All 7 versions
W Bakker, EC Eringa, P Sipkema, VWM van … - Cell and Tissue Research, 2009 - Springer Abstract Endothelial dysfunction comprises a number of functional alterations in
the vascular endothelium that are associated with diabetes and cardiovascular
disease, including changes in vasoregulation, enhanced generation of ... Cited by 3 - Related articles - All 4 versions
JM Young, N Terrin, X Wang, T Greene, GJ … - Clinical Journal of the American Society of Nephrology, 2009 - Am Soc Nephrol Results: Mean (SD) age was 52 (12) yr, GFR was 32 ± 12 ml/min per 1.73 m 2 ,
and ADMA was 0.70 ± 0.25 µmol/L. A 1-SD increase in ADMA was associated with a
31% increased odds of prevalent CVD in an adjusted logistic regression ... Cited by 3 - Related articles - All 3 versions
M Marcovecchio, B Widmer, D Dunger, R … - Clinical Science, 2008 - submit.clinsci.org ADMA (asymmetric dimethylarginine), an endogenous inhibitor of nitric oxide
synthase, is considered a major risk factor for cardiovascular disease and
progression of renal disease. In the present study we aim to investigate ... Cited by 2 - Related articles - Cached - All 7 versions
K Hanai, T Babazono, I Nyumura, K Toya, N … - Nephrology Dialysis Transplantation, 2009 - ERA-EDTA Results. We studied 225 diabetic patients, 81 women and 144 men, with a mean
(±SD) age of 64 ± 10 years. The majority (183) of patients were
normoalbuminuric, with the remainder microalbuminuric (42). During the ... Cited by 2 - Related articles - All 4 versions
RB Goldberg - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Evidence: Circulating biomarkers of these pathways such as TNF , IL-6,
C-reactive protein (CRP) (inflammation), vascular cellular adhesion molecule-1,
interstitial cellular adhesion molecule-1, E-selectin, von Willebrand ... Cited by 2 - Related articles - All 3 versions
G Schernthaner, K Krzyzanowska - Biomarkers Med., 2008 - Future Medicine Asymmetric dimethylarginine causes endothelial dysfunction in forearm resistance
arteries [4]. It increases the systemic vascular resistance and arterial blood
pressure and decreases cardiac output [5]. Owing to its biological actions ... Cited by 1 - Related articles - All 3 versions
RH Böger, R Maas, F Schulze, E Schwedhelm - Pharmacological Research, 2009 - Elsevier Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide
(NO) synthases. By inhibiting NO formation, ADMA causes endothelial dysfunction,
vasoconstriction, elevation of blood pressure, and aggravation of ... Cited by 1 - Related articles - All 2 versions
E Cavusoglu, C Ruwende, V Chopra, S … - Coronary artery disease, 2009 - journals.lww.com Background Nitric oxide (NO) is produced from L-arginine by NO synthase and is
an important molecule with antiatherogenic properties. Asymmetric
dimethylarginine (ADMA) acts as an endogenous inhibitor of endothelial NO ... Cited by 1 - Related articles - All 6 versions
